MorphoTrak has announced that its Board of Directors has announced the election of Daniel Vassy as its President and CEO to the Board of Directors of the International Biometric industry Association (IBIA). The IBIA is a non-profit trade association focused on the promotion of biometric technology to effectively determine identity and enhance security, privacy, productivity, and convenience for individuals, organizations, and governments around the world. Mr. Vassy is proud to be selected for the position, noting that the Association’s educational, lobbying, and outreach efforts have increased awareness of biometric technology value.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
MorphoTrak, Inc., a subsidiary of Safran USA, provides biometric and identity management solutions to the U.S. and Canadian markets. Formed in April 2009 from the merger of Sagem Morpho Inc. and Motorola's biometric division, Printrak, MorphoTrak’s markets include law enforcement, border control, civil identification, facility/IT security and access control. MorphoTrak and its global parent Sagem Sécurité - part of the Safran group - are leading innovators in large fingerprint identification systems, facial and iris recognition, as well as identification licenses. MorphoTrak employs over 450 persons in the U.S., with headquarters near Washington D.C., major corporate facilities in Anaheim, CA and Tacoma, WA, and regional facilities throughout the U.S.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
